The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
January 23rd 2025
The fast-track designation follows the FDA orphan drug designation that was granted for DYNE-101 in September 2023 for the same treatment population.
Understanding the Impact of Allelic Gene Variants on Pediatric Pain Relief
January 9th 2024Studies have shown that higher expression of CYP2D6 alleles in adults results in excessive production of active metabolites, leading to either therapeutic failure, increased exposure, or more severe adverse effects.
Read More
Study: Machine Learning Can Predict Early Alzheimer Disease, But Has Racial, Ethnic Unfairness
January 5th 2024Although machine learning models demonstrate potential to improve early detection of Alzheimer disease, sample sizes that underrepresent ethnic and racial groups result in unfairness.
Read More
Investigating Etoposide Adverse Reactions Associated with Polyethersulfone Filter
January 4th 2024This study showed the importance of a multidisciplinary team’s expertise to investigate a clinical inquiry beyond the scope of the clinicians’ skillset and their access to necessary technology.
Read More
Cognitive Tests Via Smartphone Help Identify Early Amyloid Changes Associated With Alzheimer Disease
January 4th 2024The pattern for the diminished learning curve, associated with elevated amyloid levels, was consistent across 3 memory tasks, with strongest results for recalling digit-signs and groceries prices.
Read More
No Difference Observed Between Branded, Biosimilar Enoxaparin for Post-Operative Thrombosis
January 4th 2024There was no statistically significant difference between Lovenox (Sanofi–Aventis Pharmaceuticals, France) and biosimilar enoxaparin in the occurrence of post-operative thrombosis for digestive cancer.
Read More